These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3759735)

  • 21. [Susceptibility of clinical bacterial isolates to aztreonam].
    Murase M; Niiya T; Takeuchi N
    Jpn J Antibiot; 1987 Sep; 40(9):1698-706. PubMed ID: 3121888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential modulation of the induction of inflammatory mediators by antibiotics in mouse macrophages in response to viable Gram-positive and Gram-negative bacteria.
    Cui W; Lei MG; Silverstein R; Morrison DC
    J Endotoxin Res; 2003; 9(4):225-36. PubMed ID: 12935353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in-vitro activity of SQ 82,291, a new monobactam, in comparison with aztreonam.
    García-Rodríguez JA; García-Sánchez JE; Plata A; Trujillano I
    J Antimicrob Chemother; 1986 Mar; 17(3):303-7. PubMed ID: 3754552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Belgian multicentre study on the in vitro activity of cefepime against gram-negative bacilli.
    Verbist L; Glupczynski Y
    Acta Clin Belg; 1996; 51(1):28-35. PubMed ID: 8669160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
    Wundt W; Lange KP; Baumgärtner M
    Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antimicrobial properties of substituted 3-aminoxypropionyl and 3-aminoxy-(E)-2-methoxyiminopropionyl monobactams.
    Balsamo A; Macchia B; Orlandini E; Rossello A; Macchia F; Broccali G; Fonio W
    Farmaco; 1990 Jul; 45(7-8):879-88. PubMed ID: 2282121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monobactam antibiotics in subinhibitory concentrations enhance opsonophagocytosis and serum bacteriolysis in certain Escherichia coli strains.
    Veringa E; Box A; Rozenberg-Arska M; Verhoef J
    Drugs Exp Clin Res; 1988; 14(1):1-8. PubMed ID: 3292179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of tigemonam against urinary tract pathogens.
    Garcia-Rodriguez JA; Garcia-Sanchez JE
    J Chemother; 1989 May; 1 Suppl 2():28-31. PubMed ID: 2809699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of tigemonam against multiresistant nosocomial Enterobacteriaceae.
    Giamarellou H; Pephanis A; Grammatikou M; Avlamis A; Papoulias G
    J Chemother; 1989 May; 1 Suppl 2():32-5. PubMed ID: 2809700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae - Identification of LYS228.
    Reck F; Bermingham A; Blais J; Capka V; Cariaga T; Casarez A; Colvin R; Dean CR; Fekete A; Gong W; Growcott E; Guo H; Jones AK; Li C; Li F; Lin X; Lindvall M; Lopez S; McKenney D; Metzger L; Moser HE; Prathapam R; Rasper D; Rudewicz P; Sethuraman V; Shen X; Shaul J; Simmons RL; Tashiro K; Tang D; Tjandra M; Turner N; Uehara T; Vitt C; Whitebread S; Yifru A; Zang X; Zhu Q
    Bioorg Med Chem Lett; 2018 Feb; 28(4):748-755. PubMed ID: 29336873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility of 310 nonfermentative gram-negative bacteria to aztreonam, carumonam, ciprofloxacin, ofloxacin and fleroxacin.
    Appelbaum PC; Spangler SK; Tamarree T
    Chemotherapy; 1988; 34(1):40-5. PubMed ID: 3127127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular activity of cefamandole and aztreonam against phagocytosed Escherichia coli and Staphylococcus aureus.
    Adinolfi LE; Utili R; Dilillo M; Tripodi MF; Attanasio V; Ruggiero G
    J Antimicrob Chemother; 1989 Dec; 24(6):927-35. PubMed ID: 2695512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial activity of tigemonam dicholate (SQ 30836) and interaction with beta-lactamases of gram-negative bacteria.
    Raimondi A; Cocuzza CE
    J Chemother; 1989 May; 1 Suppl 2():13-21. PubMed ID: 2809698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbapenems and monobactams: imipenem, meropenem, and aztreonam.
    Hellinger WC; Brewer NS
    Mayo Clin Proc; 1999 Apr; 74(4):420-34. PubMed ID: 10221472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Brogden RN; Heel RC
    Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of subinhibitory concentrations of cefotaxime on adhesion and polymorphonuclear leukocyte function with gram-negative bacteria.
    Bassaris HP; Lianou PE; Votta EG; Papavassiliou JT
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():91-6. PubMed ID: 6094466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamic effects of subinhibitory antibiotic concentrations.
    Tornqvist IO; Holm SE; Cars O
    Scand J Infect Dis Suppl; 1990; 74():94-101. PubMed ID: 2097721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the in vitro activity of aztreonam on 1990 gram-negative bacterial strains recently isolated in Campania hospitals].
    Covelli I; Bolletti-Censi M; Fortunato A; Guarino A; Spagnoletti G; Amato G; Nani E; Anzivino D; Lavitola A; Gulletta E
    Boll Ist Sieroter Milan; 1986; 65(1):22-31. PubMed ID: 3521671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibacterial activity of aztreonam against clinical isolates].
    Igari J
    Jpn J Antibiot; 1994 May; 47(5):502-20. PubMed ID: 8051793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli.
    Critchley IA; Sahm DF; Kelly LJ; Karlowsky JA
    Chemotherapy; 2003 May; 49(1-2):44-8. PubMed ID: 12714810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.